Tuesday, March 17, 2026

Alteogen Secures U.S. Patent for Keytruda Subcutaneous Injection: What This Means for ALT-B4 and Future Treatments

Alteogen secures a U.S. patent for a subcutaneous Keytruda formulation using ALT-B4, ensuring exclusivity until 2043 and potential $1B in sales.

Why Demon Slayer Missed Out on the Golden Globe Despite Record-Breaking Success

Japanese media expressed disappointment that "Demon Slayer" missed a Golden Globe despite its box office success. "K-Pop Demon Hunters" won instead.

Nuclear Arsenal: Is it Essential for North Korea’s Survival? Insights from Kim Son-kyung’s UN Address

North Korea emphasizes its nuclear status through Kim Sun-kyung's UN speech, portraying nuclear arms as essential for survival.

Tag: shiny

North KoreaKoreaKimMilitarySouth KoreaAIrelationsmarketInternational

No posts to display

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.